Two “Compassionate Use” Expanded Access Programs (EAPs) provided access to treatment with CNM-Au8 to more than 250 people living with amyotrophic lateral sclerosis (ALS). A significant survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback